A Long-Term Storage Business Model Centered on Private Umbilical Cord Blood Banks
First written in FY2021. 6 of 8 entries say "Advanced", first in FY2023. Latest entry: FY2026.
1 other company's latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「Advance receipts from customers for umbilical cord blood and umbilical cord storage services amounted to ¥4,127 million.」
The cumulative number of umbilical cord blood and umbilical cord specimens in storage exceeded 110,000, and advance receipts corresponding to future storage revenue amounted to ¥4,127 million. The recurring revenue base from the long-term storage business expanded. - FY2026-H1AdvancedAnnual report
「As the number of customers storing both umbilical cord blood and umbilical cords increases, deferred storage fees, which represent advance receipts for future storage revenue, are also increasing.」
The company explains that deferred storage fees, which will generate future recurring revenue, increased as the number of customers storing both umbilical cord blood and umbilical cords rose. - FY2025AdvancedAnnual report
「Fiscal year ended March 2025 8,464 specimens 94,683 specimens 4,745 specimens 13,210 specimens」
The annual number of umbilical cord blood specimens placed in storage was 8,464, with a cumulative total of 94,683, while the corresponding figures for umbilical cords were 4,745 and 13,210, respectively, indicating expansion of the long-term storage business model. - FY2023AdvancedAnnual report
「Fiscal year ended March 2023 7,564 specimens 77,660 specimens 2,907 specimens 4,418 specimens」
The company continues its long-term storage business model. The cumulative number of umbilical cord blood specimens in storage reached 77,660, while the cumulative number of umbilical cord specimens reached 4,418. - FY2022RestatedAnnual report
「Fiscal year ended March 2022 6,907 specimens 70,096 specimens 1,511 specimens 1,511 specimens」
The company continues to operate a long-term storage business model under which umbilical cord blood is separated and prepared for long-term storage, with separation, testing, registration and storage fees collected. The cumulative number of umbilical cord blood specimens in storage reached 70,096 in the fiscal year ended March 2022. - FY2021First statedAnnual report
「After entering into an "Umbilical Cord Blood Separation and Storage Outsourcing Agreement" with customers, such as expectant mothers, the company collects umbilical cord blood taken at cooperating hospitals in Japan, including university hospitals and obstetric clinics, and transports it to its cell processing center in Minato-ku, Tokyo. It then separates, extracts and prepares the stem cells contained in the umbilical cord blood before storing them long term at ultra-low temperatures at its cell storage center in Midori-ku, Yokohama, Kanagawa Prefecture.」
A business model that collects separation, testing, registration and storage fees and stores specimens long term for future use. The cumulative number of specimens in storage was 63,189 in the fiscal year ended March 2021.